Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like Hexagon announces OPTIV M CMM multisensor November 11, 2019 Dell announces Latitude 7220 Rugged Extreme tablet October 30, 2019 Amazon preps for a heated race against Flipkart as holiday sales kick off September 21, 2017